DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Temovate E (Clobetasol Propionate Topical (Emollient)) - Indications and Dosage

 
 



INDICATIONS AND USAGE

Temovate® E is a super-high potency corticosteroid indicated for:

Corticosteroid-Responsive Dermatoses

Temovate® E is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 12 years of age and older. Treatment should be limited to 2 consecutive weeks, and the total dosage should not exceed 50 grams per week.

Moderate to Severe Plaque-Type Psoriasis

Temovate®E is indicated for the topical treatment of moderate to severe plaque-type psoriasis. Treatment beyond 4 consecutive weeks is not recommended. Use in pediatric patients under 16 years of age is not recommended.

Limitations of Use

Temovate® E should not be used in the treatment of rosacea or perioral dermatitis, and should not be used on the face, groin, or axillae.

The total dosage should not exceed 50 grams per week.

Avoid use if skin atrophy is present at the treatment site.

DOSAGE AND ADMINISTRATION

Apply a thin layer of Temovate® E to the affected skin areas twice daily and rub in gently and completely. Wash hands after each application.

Temovate® E is a super-high potency topical corticosteroid; therefore, treatment should be limited to 2 consecutive weeks, and amounts greater than 50 grams per week should not be used.

In moderate to severe plaque-type psoriasis, Temovate® E applied to 5% to 10% of body surface area can be used for up to 4 weeks. The total dosage should not exceed 50 grams per week. When dosing for more than 2 weeks, any additional benefits of extending treatment should be weighed against the risk of HPA suppression. Therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Treatment beyond 4 consecutive weeks is not recommended.

Temovate® E should not be used with occlusive dressings.

DOSAGE FORMS AND STRENGTHS

Cream, 0.05%. Each gram of Temovate® E Cream contains 0.5 mg of clobetasol propionate in a white to off-white cream base.

HOW SUPPLIED/STORAGE AND HANDLING

How Supplied
Temovate® E (clobetasol propionate) Cream, 0.05% is a white to off-white cream, supplied in 60 g tubes (NDC 10337-301-60).

Storage and Handling

Store between 15°C and 30°C (59°F and 86°F)

Temovate® E should not be refrigerated.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017